Confirmation of drug delivery after liver chemoembolization: Direct tissue doxorubicin measurement by UHPLC-MS-MS

Biomedical Chromatography

Volumn 26, Issue 12, 2012, Pages 1529-1533

  Baumgarten, Sigrid ^a   Gaba, Ron C ^a   Van Breemen, Richard B ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Chemoembolization; Doxorubicin; Lipiodol; Tandem mass spectrometry; UHPLC

Indexed keywords

COMPUTERIZED TOMOGRAPHY; CONTROLLED DRUG DELIVERY; DISEASES; DRUG PRODUCTS; EMULSIFICATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; TARGETED DRUG DELIVERY;

BLOOD FLOW; CHEMOEMBOLIZATION; DEVELOPMENT AND APPLICATIONS; DOXORUBICIN; LIPIODOL; LIVER CANCERS; LIVER TUMORS; TANDEM MASS SPECTROMETRY; TANDEM-MASS SPECTROMETRY; UHPLC;

TUMORS;

DAUNORUBICIN; DOXORUBICIN; IODINATED POPPYSEED OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG STRUCTURE; DRUG TISSUE LEVEL; LIVER TUMOR; MALE; MASS SPECTROMETRY; NONHUMAN; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ORYCTOLAGUS CUNICULUS;

EID: 84867706078     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.2727     Document Type: Article

References (24)

1. Arnold RD, Slack JE and Straubinger RM. Quantification of doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy. Journal of Chromatography B 2004; 808: 141-152.
2. Chapman WC, Majella Doyle MB, Stuart JE, Vachharajani N, Crippin JS, Anderson CD, Lowell JA, Shenoy S, Darcy MD and Brown DB. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Annals of Surgery 2008; 248: 617-625.
3. Dhanasekaran R, Khanna V, Kooby DA, Spivey JR, Parekh S, Knechtle SJ, Carew JD, Kauh JS and Kim HS. The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma. Journal of Vascular and Interventional Radiology 2010; 21: 1197-1204.
4. Fujita T, Ito K, Tanabe M, Yamatogi S, Sasai H and Matsunaga N. Iodized oil accumulation in hypervascular hepatocellular carcinoma after transcatheter arterial chemoembolization: comparison of imaging findings with CT during hepatic arteriography. Journal of Vascular and Interventional Radiology 2008; 19: 333-341.
5. Gaba RC. Abstract No. 283: A survey of chemoembolization practice patterns and technical methodologies among interventional radiologists Journal of Vascular and Interventional Radiology 2011; 22: S119-S120.
6. Ko YH, Pedersen PL and Geschwind JF. Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Letters 2001; 173: 83-91.
7. Kozutsumi D, Ohshiba Y, Sugimoto T, Tsuboi H, Kawashima A, Kochiya M, Adachi M and Takami M. A new assay for lipiodol in a tumor using a combination of m-chloroperbenzoic acid-mediated oxidation and the iodo-starch reaction. Cancer Letters 2000; 158: 93-98.
8. Lewandowski RJ, Kulik LM, Riaz A, Senthilnathan S, Mulcahy MF, Ryu RK, Ibrahim SM, Sato KT, Baker T, Miller FH, Omary R, Abecassis M and Salem R. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. American Journal of Transplantation 2009; 9: 1920-1928.
9. Licata S, Saponiero A, Mordente A and Minotti G. Doxorubicin metabolism and toxicity in human myocardium: role of cytoplasmic deglycosidation and carbonyl reduction. Chemical Research in Toxicology 2000; 13: 414-420.
10. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Solá R, Rodés J and Bruix J. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Barcelona Clinic Liver Cancer Group. Lancet 2002; 359: 1734-1739.
11. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST and Wong J. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-1171.
12. Monneret C and Sellier N. Desorption chemical ionization mass spectrometry of anthracyclines and of trisaccharides related to aclacinomycin A and marcellomycin. Biomedical & Environmental Mass Spectrometry 1986; 13: 319-326.
13. Owu E, Al-Mufti R and Winslet M. Uptake of lipiodol-cytotoxics conjugates by hepatocellular carcinoma cells. Journal of Pediatric Surgery 2004; 39: 203-206.
14. Parkin DM, Bray F, Ferlay J and Pisani P. Global cancer statistics, 2002. CA: a Cancer Journal for Clinicians 2005; 55: 74.
15. Ramsey DE, Kernagis LY, Soulen MC and Geschwind JH. Chemoembolization of hepatocellular carcinoma. Journal of Vascular and Interventional Radiology 2002; 13: S211-S221.
16. Raoul JL. Natural history of hepatocellular carcinoma and current treatment options. Seminars in Nuclear Medicine 2008; 38: S13-S18.
17. Requarth J. Image-guided palliative care procedures. The Surgical Clinics of North America 2011; 91: 367-402.
18. Satake M, Uchida H, Arai Y, Anai H, Sakaguchi H, Nagata T, Yamane T, Kichikawa K, Osaki Y, Okazaki M, Higashihara H, Nakamura H, Osuga K, Nakao N and Hirota S. Transcatheter arterial chemoembolization (TACE) with lipiodol to treat hepatocellular carcinoma: survey results from the TACE study group of Japan. Cardiovascular and Interventional Radiology 2008; 31: 756-761.
19. Schutte K, Bornschein J and Malfertheiner P. Hepatocellular carcinoma - epidemiological trends and risk factors. Digestive Diseases (Basel, Switzerland) 2009; 27: 80-92.
20. Sottani C, Leoni E, Porro B, Montagna B, Amatu A, Sottotetti F, Quaretti P, Poggi G and Minoia C. Validation of an LC-MS/MS method for the determination of epirubicin in human serum of patients undergoing drug eluting microsphere-transarterial chemoembolization (DEM-TACE). Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2009; 877: 3543-3548.
21. Taguchi K, Funama Y, Zhang M, Fishman EK and Geschwind JF. Quantitative measurement of iodine concentration in the liver using abdominal C-arm computed tomography. Academic Radiology 2009; 16: 200-208.
22. Virmani S, Harris KR, Szolc-Kowalska B, Paunesku T, Woloschak GE, Lee FT, Lewandowski RJ, Sato KT, Ryu RK, Salem R, Larson AC and Omary RA. Comparison of two different methods for inoculating VX2 tumors in rabbit livers and hind limbs. Journal of Vascular and Interventional Radiology 2008; 19: 931-936.
23. Wang Y, Hong J, Cressman EN and Arriaga EA. Direct sampling from human liver tissue cross sections for electrophoretic analysis of doxorubicin. Analytical Chemistry 2009; 81: 3321-3328.
24. Weiss RB. The anthracyclines: will we ever find a better doxorubicin? Seminars in Oncology 1992; 19: 670-686.